Prophylactic vancomycin for very-low-birthweight infants. 1992

M J Horgan, and M A Kacica, and R A Venezia

UI MeSH Term Description Entries
D007230 Infant, Low Birth Weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. Low Birth Weight,Low-Birth-Weight Infant,Birth Weight, Low,Birth Weights, Low,Infant, Low-Birth-Weight,Infants, Low-Birth-Weight,Low Birth Weight Infant,Low Birth Weights,Low-Birth-Weight Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias

Related Publications

M J Horgan, and M A Kacica, and R A Venezia
October 1992, Lancet (London, England),
M J Horgan, and M A Kacica, and R A Venezia
August 2020, The Journal of antimicrobial chemotherapy,
M J Horgan, and M A Kacica, and R A Venezia
January 1992, Developmental pharmacology and therapeutics,
M J Horgan, and M A Kacica, and R A Venezia
January 1988, American journal of perinatology,
M J Horgan, and M A Kacica, and R A Venezia
December 1997, The Journal of hospital infection,
M J Horgan, and M A Kacica, and R A Venezia
December 1998, Changgeng yi xue za zhi,
M J Horgan, and M A Kacica, and R A Venezia
June 2002, Journal of the South Carolina Medical Association (1975),
M J Horgan, and M A Kacica, and R A Venezia
May 1985, Nippon Ganka Gakkai zasshi,
M J Horgan, and M A Kacica, and R A Venezia
August 1992, Lancet (London, England),
M J Horgan, and M A Kacica, and R A Venezia
May 1995, Israel journal of medical sciences,
Copied contents to your clipboard!